Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

NCT00429559 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Hycamptin
DRUG: Gemcitabine

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]